Войти Добавить текст
Вы здесь:
Оглавление: Ожирение
------ Страница 67 ------

Ожирение - Страница 67

E. T. et al., The effect of

exercise-training on resting metabolic rate in lean and moderately obese

individuals. Int. J. Obes. 1986 10 511-517.

227. Valtuena S; Blanch S; Barenys M; Sola R; Salas-Salvado J Changes in

body composition and resting energy expenditure after rapid weight loss: is

there an energy-metabolism adaptation in obese patients? Int J Obes Relat

Metab Disord 1995 Feb;19(2):119-25

228. van Baak MA Exercise training and substrate utilisation in obesity.

Int J Obes Relat Metab Disord 1999 Apr;23 Suppl 3:S11-7

229. Vander Tuig JG, Beneke WM Low-protein diet blocks development of

hyperphagia and obesity in rats with hypothalamic knife cuts. J Nutr 1996

Jun;126(6):1713-21

230. Vara L., Agras S Caloric intake and activity levels are related in

yong children Int. J. Obes. 1989 13 613-617.

231. Viru A., Smirnova T. Health promotion and exercise training //

Sports Med. - 1995. - Vol. 19. - P. 123-136.

232. Wannamathee G., Shaper A. G. Weight change in middle-aged British

men: implications for health. Eur. J. Clin. Nutr. 1989 44 133-142

233. Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT Prevalence of

valvular-regurgitation associated with dexfenfluramine three to five months

after discontinuation of treatment. J Am Coll Cardiol 1999 Dec;34(7):2088-95

234. Wells JC Is obesity really due to high energy intake or low energy

expenditure? Int J Obes Relat Metab Disord 1998 Nov;22(11):1139-40

235. Weyer C, Snitker S, Rising R, Bogardus C, Ravussin E Determinants of

energy expenditure and fuel utilization in man: effects of body composition,

age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat

Metab Disord 1999 Jul;23(7):715-22

236. Wilkinson P. W., Parkin J. M., Pearlson G. et al., Energy intake and

physical activity in obese children. Br. Med. J. 1977, i 756

237. Willett WC Is dietary fat a major determinant of body fat? Am J Clin

Nutr 1998;67:556S-562S.

238. Williams KV, Mullen ML, Kelley DE, Wing RR The effect of short

periods of caloric restriction on weight loss and glycemic control in type 2

diabetes. Diabetes Care 1998 Jan;21(1):2-8

239. Wilmore JH Increasing physical activity: alterations in body mass

and composition. Am J Clin Nutr 1996 Mar;63(3 Suppl):456S-460S

240. Wing RR. Use of very-low-calorie diets in the treatment of obese

persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1995

May;95(5):569-72; quiz 573-4

241. Wolf A. M.; Colditz G. A. Social and economic effects of body weight

in the United States. Am. J. Clin. Nutr. 1996. - V. 63., N3. (Suppl). - P.

466S-469S

242. Wong J, Reddy SS, Klein AL Anorectic drugs and valvular heart

disease: a biological and clinical perspective. Cleve Clin J Med 1998

Jan;65(1):35-41

243. Wurtman J, Wurtman R, Reynolds S et al., D-fenfluramine supresses

snack intake among carbohydrate cravers but not among non-carbohydrate

cravers. Inter. J. Eat. Disord.- 1987. - V.6.,N8. - P. 687-699.

244. Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S;

Ozawa N; Suzuki Y; Maeno H; Kato K; et al., Daily walking combined with diet

therapy is a useful means for obese NIDDM patients not only to reduce body

weight but also to improve insulin sensitivity. Diabetes Care 1995

Jun;18(6):775-8

245. Yki-Jarvinen H, Nikkila K, Makimattila S Metformin prevents weight

gain by reducing dietary intake during insulin therapy in patients with type

2 diabetes mellitus. Drugs 1999;58 Suppl 1:53-4; discussion 75-82

246. Zhi J., Melia A. T., Guerciolini R., et al., Retrospective

population-based analysis of the dose-response (fecal fat excretion)

relationship of orlistat in normal and obese volunteers. Clin Pharmacol.

Ther. 1994 56 82-85].

247. Zhi J; Melia AT; Eggers H; Joly R; Patel IH Review of limited

systemic absorption of orlistat, a lipase inhibitor, in healthy human

volunteers. J Clin Pharmacol 1995 Nov;35(11):1103-8].

248. Zimmet P, Collier G Clinical efficacy of metformin against insulin

resistance parameters: sinking the iceberg. Drugs 1999;58 Suppl 1:21-8;

discussion

Навигация:

Страница 1
Страница 68
-- Страница 67 --
Страница 66
Страница 65